{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T01:56:06Z","timestamp":1774058166688,"version":"3.50.1"},"reference-count":98,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"am","delay-in-days":349,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"publisher","award":["K23 HL150237-01"],"award-info":[{"award-number":["K23 HL150237-01"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.rdc.2025.01.002","type":"journal-article","created":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T13:38:08Z","timestamp":1741268288000},"page":"213-231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Advancing Gastrointestinal Microbiota Research in Systemic Sclerosis"],"prefix":"10.1016","volume":"51","author":[{"given":"Chiara","family":"Bellocchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth R.","family":"Volkmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.rdc.2025.01.002_bib1","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1111\/j.1753-4887.2012.00493.x","article-title":"Defining the human microbiome","volume":"70 Suppl 1","author":"Ursell","year":"2012","journal-title":"Nutr Rev"},{"key":"10.1016\/j.rdc.2025.01.002_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.906258","article-title":"Microbial dysbiosis in the gut drives systemic autoimmune diseases","volume":"13","author":"Mousa","year":"2022","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.rdc.2025.01.002_bib3","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41422-020-0332-7","article-title":"Interaction between microbiota and immunity in health and disease","volume":"30","author":"Zheng","year":"2020","journal-title":"Cell Res"},{"issue":"3","key":"10.1016\/j.rdc.2025.01.002_bib4","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/1744666X.2023.2161512","article-title":"Is there a role for the microbiome in systemic sclerosis?","volume":"19","author":"Volkmann","year":"2023","journal-title":"Expert Rev Clin Immunol"},{"issue":"8","key":"10.1016\/j.rdc.2025.01.002_bib5","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s11926-018-0758-9","article-title":"Update on the gastrointestinal microbiome in systemic sclerosis","volume":"20","author":"Bellocchi","year":"2018","journal-title":"Curr Rheumatol Rep"},{"issue":"5","key":"10.1016\/j.rdc.2025.01.002_bib6","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/acr2.11387","article-title":"Disease features and gastrointestinal microbial composition in patients with systemic sclerosis from two independent cohorts","volume":"4","author":"Andr\u00e9asson","year":"2022","journal-title":"ACR Open Rheumatol"},{"issue":"6","key":"10.1016\/j.rdc.2025.01.002_bib7","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1002\/art.39572","article-title":"Association of systemic sclerosis with a unique colonic microbial consortium","volume":"68","author":"Volkmann","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"10373","key":"10.1016\/j.rdc.2025.01.002_bib8","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0140-6736(22)01692-0","article-title":"Systemic sclerosis","volume":"401","author":"Volkmann","year":"2023","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.rdc.2025.01.002_bib9","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s13075-020-02329-2","article-title":"Health Assessment Questionnaire-Disability Index (HAQ-DI) use in modelling disease progression in diffuse cutaneous systemic sclerosis: an analysis from the EUSTAR database","volume":"22","author":"Allanore","year":"2020","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"10.1016\/j.rdc.2025.01.002_bib10","doi-asserted-by":"crossref","first-page":"3646","DOI":"10.1093\/rheumatology\/keaa827","article-title":"Health-related quality of life in patients with systemic sclerosis: evolution over time and main determinants","volume":"60","author":"van Leeuwen","year":"2021","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.rdc.2025.01.002_bib11","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/acr2.11126","article-title":"Increased mortality in asians with systemic sclerosis in northern California","volume":"2","author":"Chung","year":"2020","journal-title":"ACR Open Rheumatol"},{"issue":"3","key":"10.1016\/j.rdc.2025.01.002_bib12","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.semarthrit.2019.11.005","article-title":"Mortality and hospitalization outcomes of interstitial lung disease and pulmonary hypertension in the Singapore systemic sclerosis cohort","volume":"50","author":"Noviani","year":"2020","journal-title":"Semin Arthritis Rheum"},{"issue":"45","key":"10.1016\/j.rdc.2025.01.002_bib13","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000031780","article-title":"Gastrointestinal involvement in systemic sclerosis: an updated review","volume":"101","author":"Nassar","year":"2022","journal-title":"Medicine (Baltim)"},{"issue":"2","key":"10.1016\/j.rdc.2025.01.002_bib14","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nrg3642","article-title":"Sequencing depth and coverage: key considerations in genomic analyses","volume":"15","author":"Sims","year":"2014","journal-title":"Nat Rev Genet"},{"issue":"8","key":"10.1016\/j.rdc.2025.01.002_bib15","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gku169","article-title":"MyTaxa: an advanced taxonomic classifier for genomic and metagenomic sequences","volume":"42","author":"Luo","year":"2014","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"10.1016\/j.rdc.2025.01.002_bib16","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.bbrc.2015.12.083","article-title":"Analysis of the microbiome: advantages of whole genome shotgun versus 16S amplicon sequencing","volume":"469","author":"Ranjan","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.rdc.2025.01.002_bib17","doi-asserted-by":"crossref","first-page":"110","DOI":"10.33590\/emj\/20-00043","article-title":"Longitudinal characterisation of the gastrointestinal tract microbiome in systemic sclerosis","volume":"7","author":"Volkmann","year":"2020","journal-title":"Eur Med J (Chelmsf)"},{"issue":"6","key":"10.1016\/j.rdc.2025.01.002_bib18","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01713-16","article-title":"Patient-specific Bacteroides genome variants in pouchitis","volume":"7","author":"Vineis","year":"2016","journal-title":"mBio"},{"key":"10.1016\/j.rdc.2025.01.002_bib19","doi-asserted-by":"crossref","DOI":"10.1111\/jgh.14129","article-title":"Comparison of the microbial community structure between inflamed and non-inflamed sites in patients with ulcerative colitis","author":"Hirano","year":"2018","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.rdc.2025.01.002_bib20","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.jcmgh.2016.06.004","article-title":"A\u00a0disease-associated microbial and metabolomics state in relatives of pediatric inflammatory bowel disease patients","volume":"2","author":"Jacobs","year":"2016","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.rdc.2025.01.002_bib21","author":"Benjamini"},{"key":"10.1016\/j.rdc.2025.01.002_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/s41577-024-01014-8","article-title":"Short-chain fatty acids: linking diet, the microbiome and immunity","author":"Mann","year":"2024","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.rdc.2025.01.002_bib23","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/gut.26.1.81","article-title":"Intraepithelial lymphocytes of human gut: isolation, characterisation and study of natural killer activity","volume":"26","author":"Cerf-Bensussan","year":"1985","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.rdc.2025.01.002_bib24","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s13075-016-1182-z","article-title":"Intestinal dysbiosis is common in systemic sclerosis and associated with gastrointestinal and extraintestinal features of disease","volume":"18","author":"Andr\u00e9asson","year":"2016","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.rdc.2025.01.002_bib25","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2017-000134","article-title":"Systemic sclerosis is associated with specific alterations in gastrointestinal microbiota in two independent cohorts","volume":"4","author":"Volkmann","year":"2017","journal-title":"BMJ Open Gastroenterol"},{"issue":"1","key":"10.1016\/j.rdc.2025.01.002_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-14889-6","article-title":"Gut microbiota profile in systemic sclerosis patients with and without clinical evidence of gastrointestinal involvement","volume":"7","author":"Patrone","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.rdc.2025.01.002_bib27","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/nyas.13736","article-title":"Microbial and metabolic multi-omic correlations in systemic sclerosis patients","volume":"1421","author":"Bellocchi","year":"2018","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"10.1016\/j.rdc.2025.01.002_bib28","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/ard.2010.136929","article-title":"Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a delphi consensus study from EULAR scleroderma trials and research group","volume":"70","author":"Avouac","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.rdc.2025.01.002_bib29","first-page":"1573","article-title":"Criteria for the classification of early systemic sclerosis","volume":"28","author":"LeRoy","year":"2001","journal-title":"J\u00a0Rheumatol"},{"issue":"11","key":"10.1016\/j.rdc.2025.01.002_bib30","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1016\/j.jid.2017.06.019","article-title":"Early-life antibiotic exposure causes intestinal dysbiosis and exacerbates skin and lung pathology in experimental systemic sclerosis","volume":"137","author":"Mehta","year":"2017","journal-title":"J\u00a0Invest Dermatol"},{"issue":"3","key":"10.1016\/j.rdc.2025.01.002_bib31","first-page":"73","article-title":"Gut microbiota analysis in systemic sclerosis according to disease characteristics and nutritional status","volume":"38 Suppl 125","author":"Natalello","year":"2020","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.rdc.2025.01.002_bib32","series-title":"Scientific abstracts [internet]","first-page":"289.2","article-title":"POS0044 deciphering the gut microbiota of very early systemic sclerosis (VEDOSS) patients: a taxonomic and functional characterization","author":"Russo","year":"2024"},{"issue":"2","key":"10.1016\/j.rdc.2025.01.002_bib33","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.celrep.2017.06.060","article-title":"Peripartum antibiotics promote gut dysbiosis, loss of immune tolerance, and inflammatory bowel disease in genetically prone offspring","volume":"20","author":"Miyoshi","year":"2017","journal-title":"Cell Rep"},{"issue":"2","key":"10.1016\/j.rdc.2025.01.002_bib34","doi-asserted-by":"crossref","first-page":"132","DOI":"10.5056\/jnm22168","article-title":"Small intestinal bacterial overgrowth complicating gastrointestinal manifestations of systemic sclerosis: a systematic review and meta-analysis","volume":"29","author":"Shah","year":"2023","journal-title":"J\u00a0Neurogastroenterol Motil"},{"issue":"5","key":"10.1016\/j.rdc.2025.01.002_bib35","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/apt.13928","article-title":"Systematic review with meta-analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth","volume":"45","author":"Gatta","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"10.1016\/j.rdc.2025.01.002_bib36","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/art.24730","article-title":"Reliability and validity of the university of California, los angeles scleroderma clinical trial consortium gastrointestinal tract instrument","volume":"61","author":"Khanna","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2025.01.002_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2023.152185","article-title":"Gastrointestinal tract involvement in systemic sclerosis: the roles of diet and the microbiome","volume":"60","author":"Nguyen","year":"2023","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.rdc.2025.01.002_bib38","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.3390\/ijms24043074","article-title":"Antibiotic-therapy-induced gut dysbiosis affecting gut microbiota-brain Axis and cognition: restoration by intake of probiotics and synbiotics","volume":"24","author":"Dahiya","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.rdc.2025.01.002_bib39","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3389\/fcimb.2020.00009","article-title":"The gut-lung Axis in health and respiratory diseases: a place for inter-organ and inter-kingdom crosstalks","volume":"10","author":"Enaud","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"issue":"12","key":"10.1016\/j.rdc.2025.01.002_bib40","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.3748\/wjg.v23.i12.2124","article-title":"Diet and microbiota in inflammatory bowel disease: the gut in disharmony","volume":"23","author":"Rapozo","year":"2017","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.rdc.2025.01.002_bib41","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1378\/chest.13-0584","article-title":"Disturbed intestinal integrity in patients with COPD: effects of activities of daily living","volume":"145","author":"Rutten","year":"2014","journal-title":"Chest"},{"issue":"Supplement_5","key":"10.1016\/j.rdc.2025.01.002_bib42","doi-asserted-by":"crossref","first-page":"S339","DOI":"10.1513\/AnnalsATS.201703-255AW","article-title":"The impact of diet on immunity and respiratory diseases","volume":"14","author":"Wypych","year":"2017","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.rdc.2025.01.002_bib43","article-title":"Role of the microbiome in interstitial lung diseases","volume":"8","author":"Chioma","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"10.1016\/j.rdc.2025.01.002_bib44","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jaci.2014.06.027","article-title":"Perinatal antibiotic-induced shifts in gut microbiota have differential effects on inflammatory lung diseases","volume":"135","author":"Russell","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.rdc.2025.01.002_bib45","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3899\/jrheum.171445","article-title":"Relationship between increased fecal calprotectin levels and interstitial lung disease in systemic sclerosis","volume":"46","author":"Caimmi","year":"2019","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2025.01.002_bib46","series-title":"Scientific abstracts [internet]","first-page":"1030.1","article-title":"POS0557 fecal microbiota signatures of systemic sclerosis-associated interstitial lung disease: an exploration of the gut-lung AXIS in an international multicenter study","author":"Andr\u00e9asson","year":"2024"},{"issue":"12","key":"10.1016\/j.rdc.2025.01.002_bib47","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.3390\/nu14122479","article-title":"Bifidobacterium adolescentis is effective in relieving type 2 diabetes and may Be related to its dominant core genome and gut microbiota modulation capacity","volume":"14","author":"Qian","year":"2022","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.rdc.2025.01.002_bib48","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/mas.20108","article-title":"Mass spectrometry-based metabolomics","volume":"26","author":"Dettmer","year":"2007","journal-title":"Mass Spectrom Rev"},{"issue":"1","key":"10.1016\/j.rdc.2025.01.002_bib49","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s41522-022-00345-5","article-title":"The gut microbiome-metabolome dataset collection: a curated resource for integrative meta-analysis","volume":"8","author":"Muller","year":"2022","journal-title":"NPJ Biofilms Microbiomes"},{"issue":"1","key":"10.1016\/j.rdc.2025.01.002_bib50","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.cmet.2017.05.008","article-title":"Understanding the holobiont: how microbial metabolites affect human health and shape the immune system","volume":"26","author":"Postler","year":"2017","journal-title":"Cell Metab"},{"issue":"1","key":"10.1016\/j.rdc.2025.01.002_bib51","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13073-021-00853-7","article-title":"Congruent microbiome signatures in fibrosis-prone autoimmune diseases: IgG4-related disease and systemic sclerosis","volume":"13","author":"Plichta","year":"2021","journal-title":"Genome Med"},{"issue":"14","key":"10.1016\/j.rdc.2025.01.002_bib52","doi-asserted-by":"crossref","first-page":"7549","DOI":"10.1021\/acs.analchem.7b01381","article-title":"Coupling targeted and untargeted mass spectrometry for metabolome-microbiome-wide association studies of human fecal samples","volume":"89","author":"Melnik","year":"2017","journal-title":"Anal Chem"},{"issue":"2","key":"10.1016\/j.rdc.2025.01.002_bib53","doi-asserted-by":"crossref","first-page":"4","DOI":"10.32607\/actanaturae.11151","article-title":"Fecal metabolites as non-invasive biomarkers of gut diseases","volume":"12","author":"Zhgun","year":"2020","journal-title":"Acta Naturae"},{"issue":"1","key":"10.1016\/j.rdc.2025.01.002_bib56","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1079\/PNS2002207","article-title":"Regulation of short-chain fatty acid production","volume":"62","author":"Macfarlane","year":"2003","journal-title":"Proc Nutr Soc"},{"key":"10.1016\/j.rdc.2025.01.002_bib57","series-title":"Scientific abstracts [internet]","first-page":"1904","article-title":"AB1143 characterization of the fecal metabolome in early systemic sclerosis","author":"Young","year":"2024"},{"issue":"2","key":"10.1016\/j.rdc.2025.01.002_bib58","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/ismej.2009.112","article-title":"Interactions between gut microbiota, host genetics and diet relevant to development of metabolic syndromes in mice","volume":"4","author":"Zhang","year":"2010","journal-title":"ISME J"},{"issue":"1","key":"10.1016\/j.rdc.2025.01.002_bib59","doi-asserted-by":"crossref","first-page":"4630","DOI":"10.1038\/s41467-018-07019-x","article-title":"A\u00a0low-gluten diet induces changes in the intestinal microbiome of healthy Danish adults","volume":"9","author":"Hansen","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.rdc.2025.01.002_bib60","doi-asserted-by":"crossref","first-page":"699","DOI":"10.12688\/f1000research.18992.1","article-title":"Gut microbiome-Mediterranean diet interactions in improving host health","volume":"8","author":"Nagpal","year":"2019","journal-title":"F1000Res"},{"key":"10.1016\/j.rdc.2025.01.002_bib61","doi-asserted-by":"crossref","DOI":"10.1177\/1756284819897531","article-title":"Mechanism of action and therapeutic benefit of rifaximin in patients with irritable bowel syndrome: a narrative review","volume":"13","author":"Chey","year":"2020","journal-title":"Therap Adv Gastroenterol"},{"issue":"10","key":"10.1016\/j.rdc.2025.01.002_bib62","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1093\/rheumatology\/key175","article-title":"Treatment of small intestinal bacterial overgrowth in systemic sclerosis: a systematic review","volume":"57","author":"Pittman","year":"2018","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"10.1016\/j.rdc.2025.01.002_bib63","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nrgastro.2017.75","article-title":"Expert consensus document: the International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics","volume":"14","author":"Gibson","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.rdc.2025.01.002_bib64","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00253-017-8564-2","article-title":"Oligosaccharide biotechnology: an approach of prebiotic revolution on the industry","volume":"102","author":"Mano","year":"2018","journal-title":"Appl Microbiol Biotechnol"},{"issue":"5","key":"10.1016\/j.rdc.2025.01.002_bib65","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1365-2036.2006.03042.x","article-title":"Review article: prebiotics in the gastrointestinal tract","volume":"24","author":"Macfarlane","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.rdc.2025.01.002_bib66","first-page":"21","article-title":"The prebiotic characteristics of fructooligosaccharides are necessary for reduction of TNBS-induced colitis in rats","volume":"133","author":"Cherbut","year":"2003","journal-title":"J\u00a0Nutr"},{"issue":"7","key":"10.1016\/j.rdc.2025.01.002_bib67","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1136\/gut.2010.232025","article-title":"Randomised, double-blind, placebo-controlled trial of fructo-oligosaccharides in active Crohn\u2019s disease","volume":"60","author":"Benjamin","year":"2011","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.rdc.2025.01.002_bib68","first-page":"701","article-title":"Treatment of ulcerative colitis patients by long-term administration of germinated barley foodstuff: multi-center open trial","volume":"12","author":"Kanauchi","year":"2003","journal-title":"Int J Mol Med"},{"issue":"1","key":"10.1016\/j.rdc.2025.01.002_bib69","doi-asserted-by":"crossref","DOI":"10.1038\/ctg.2012.24","article-title":"Metabolic profiling of the impact of oligofructose-enriched inulin in Crohn\u2019s disease patients: a double-blinded randomized controlled trial","volume":"4","author":"De Preter","year":"2013","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.rdc.2025.01.002_bib70","doi-asserted-by":"crossref","first-page":"647","DOI":"10.3389\/fmicb.2016.00647","article-title":"The microbiota and health promoting characteristics of the fermented beverage Kefir","volume":"7","author":"Bourrie","year":"2016","journal-title":"Front Microbiol"},{"issue":"3","key":"10.1016\/j.rdc.2025.01.002_bib71","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1089\/jmf.2017.3990","article-title":"Lactobacillus acidophilus improves intestinal inflammation in an acute colitis mouse model by regulation of Th17 and treg cell balance and fibrosis development","volume":"21","author":"Park","year":"2018","journal-title":"J\u00a0Med Food"},{"key":"10.1016\/j.rdc.2025.01.002_bib72","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.intimp.2018.02.004","article-title":"Oral engineered Bifidobacterium longum expressing cuznsod to suppress experimental colitis","volume":"57","author":"Liu","year":"2018","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"10.1016\/j.rdc.2025.01.002_bib73","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0016-5085(00)70362-3","article-title":"Antibiotic therapy attenuates colitis in interleukin 10 gene-deficient mice","volume":"118","author":"Madsen","year":"2000","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.rdc.2025.01.002_bib74","first-page":"453","article-title":"Is lactobacillus GG helpful in children with Crohn\u2019s disease? Results of a preliminary, open-label study","volume":"31","author":"Gupta","year":"2000","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"6","key":"10.1016\/j.rdc.2025.01.002_bib75","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.explore.2016.08.015","article-title":"Probiotics for the prevention of pediatric antibiotic-associated diarrhea","volume":"12","author":"Hayes","year":"2016","journal-title":"Explore (NY)"},{"issue":"11","key":"10.1016\/j.rdc.2025.01.002_bib76","article-title":"Probiotics for treating acute infectious diarrhoea","volume":"2010","author":"Allen","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.rdc.2025.01.002_bib77","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.semarthrit.2019.05.006","article-title":"A\u00a0double-blind randomized placebo-controlled trial of probiotics in systemic sclerosis associated gastrointestinal disease","volume":"49","author":"Low","year":"2019","journal-title":"Semin Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.rdc.2025.01.002_bib78","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1093\/rheumatology\/kez160","article-title":"Effect of probiotics on gastrointestinal symptoms and immune parameters in systemic sclerosis: a randomized placebo-controlled trial","volume":"58","author":"Marighela","year":"2019","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.rdc.2025.01.002_bib79","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.BAD-0008-2017","article-title":"Fecal microbiota transplantation: therapeutic potential for a multitude of diseases beyond Clostridium difficile","volume":"5","author":"Bakker","year":"2017","journal-title":"Microbiol Spectr"},{"issue":"14","key":"10.1016\/j.rdc.2025.01.002_bib80","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.3390\/jcm11144119","article-title":"Fecal microbiota transplantation as new therapeutic avenue for human diseases","volume":"11","author":"Biazzo","year":"2022","journal-title":"JCM"},{"issue":"4","key":"10.1016\/j.rdc.2025.01.002_bib81","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/MOG.0000000000000285","article-title":"Fecal transplantation: any real hope for inflammatory bowel disease?","volume":"32","author":"Moayyedi","year":"2016","journal-title":"Curr Opin Gastroenterol"},{"issue":"5","key":"10.1016\/j.rdc.2025.01.002_bib82","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0232739","article-title":"Fecal microbiota transplantation in systemic sclerosis: a double-blind, placebo-controlled randomized pilot trial","volume":"15","author":"Fretheim","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.rdc.2025.01.002_bib83","series-title":"Scientific abstracts [internet]","first-page":"1004","article-title":"POS1310 fecal microbiota transplantation in patients with systemic sclerosis and lower gastrointestinal tract symptoms: data from the resscue randomized clinical trial","author":"Fretheim","year":"2023"},{"key":"10.1016\/j.rdc.2025.01.002_bib84","series-title":"Scientific abstracts [internet]","first-page":"177","article-title":"OP0256 efficacy of fecal microbiota transplantation on frequency of fecal incontinence symptoms in systemic sclerosis patients with moderate to severe lower gastrointestinal disease","author":"Nita","year":"2024"},{"key":"10.1016\/j.rdc.2025.01.002_bib85","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1146\/annurev-med-042320-014032","article-title":"The gut-brain Axis","volume":"73","author":"Mayer","year":"2022","journal-title":"Annu Rev Med"},{"issue":"7","key":"10.1016\/j.rdc.2025.01.002_bib86","first-page":"2558","article-title":"Irritable bowel syndrome and the gut microbiome: a comprehensive review","volume":"12","author":"Shaikh","year":"2023","journal-title":"J\u00a0Clin Med"},{"issue":"4","key":"10.1016\/j.rdc.2025.01.002_bib87","doi-asserted-by":"crossref","first-page":"e272","DOI":"10.1111\/nmo.12103","article-title":"The hypersensitivity to colonic distension of IBS patients can be transferred to rats through their fecal microbiota","volume":"25","author":"Crouzet","year":"2013","journal-title":"Neurogastroenterol Motil"},{"issue":"5","key":"10.1016\/j.rdc.2025.01.002_bib88","first-page":"2319","article-title":"Induction immunosuppression with OKT3 monoclonal antibody in cardiac transplant recipients","volume":"22","author":"Pulp\u00f3n","year":"1990","journal-title":"Transplant Proc"},{"issue":"1","key":"10.1016\/j.rdc.2025.01.002_bib89","doi-asserted-by":"crossref","DOI":"10.1136\/gpsych-2022-100893","article-title":"Alteration of faecal microbiota balance related to long-term deep meditation","volume":"36","author":"Sun","year":"2023","journal-title":"Gen Psych"},{"issue":"1","key":"10.1016\/j.rdc.2025.01.002_bib90","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12906-023-03935-8","article-title":"Isha yoga practices, vegan diet, and participation in Samyama meditation retreat: impact on the gut microbiome & metabolome - a non-randomized trial","volume":"23","author":"Raman","year":"2023","journal-title":"BMC Complement Med Ther"},{"key":"10.1016\/j.rdc.2025.01.002_bib95","article-title":"Gut microbiota associated with effectiveness and responsiveness to mindfulness-based cognitive therapy in improving trait anxiety","volume":"12","author":"Wang","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"issue":"51","key":"10.1016\/j.rdc.2025.01.002_bib98","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2110455118","article-title":"Large-scale genomic study reveals robust activation of the immune system following advanced Inner Engineering meditation retreat","volume":"118","author":"Chandran","year":"2021","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"4","key":"10.1016\/j.rdc.2025.01.002_bib99","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s10865-018-9914-y","article-title":"Yoga and immune system functioning: a systematic review of randomized controlled trials","volume":"41","author":"Falkenberg","year":"2018","journal-title":"J\u00a0Behav Med"},{"issue":"36","key":"10.1016\/j.rdc.2025.01.002_bib96","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000035044","article-title":"Intervention study of tai chi training on the intestinal flora of college student basketball players","volume":"102","author":"Kang","year":"2023","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.rdc.2025.01.002_bib97","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jad.2023.02.002","article-title":"Effects of exercise or tai chi on Internet addiction in college students and the potential role of gut microbiota: a randomized controlled trial","volume":"327","author":"Zhang","year":"2023","journal-title":"J\u00a0Affect Disord"},{"key":"10.1016\/j.rdc.2025.01.002_bib100","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.721758","article-title":"Comparative study of the effects of tai chi and square dance on immune function, physical health, and life satisfaction in urban empty-nest older adults","volume":"12","author":"Su","year":"2021","journal-title":"Front Physiol"},{"issue":"5717","key":"10.1016\/j.rdc.2025.01.002_bib91","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1126\/science.1104816","article-title":"Host-bacterial mutualism in the human intestine","volume":"307","author":"B\u00e4ckhed","year":"2005","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.rdc.2025.01.002_bib92","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/s41579-019-0191-8","article-title":"The ancestral and industrialized gut microbiota and implications for human health","volume":"17","author":"Sonnenburg","year":"2019","journal-title":"Nat Rev Microbiol"},{"issue":"7402","key":"10.1016\/j.rdc.2025.01.002_bib93","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature11053","article-title":"Human gut microbiome viewed across age and geography","volume":"486","author":"Yatsunenko","year":"2012","journal-title":"Nature"},{"issue":"33","key":"10.1016\/j.rdc.2025.01.002_bib94","doi-asserted-by":"crossref","first-page":"14691","DOI":"10.1073\/pnas.1005963107","article-title":"Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa","volume":"107","author":"De Filippo","year":"2010","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X2500002X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X2500002X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T11:16:03Z","timestamp":1750331763000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X2500002X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":98,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0889857X2500002X"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2025.01.002","relation":{},"ISSN":["0889-857X"],"issn-type":[{"value":"0889-857X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advancing Gastrointestinal Microbiota Research in Systemic Sclerosis","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2025.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}